Scientific and clinical research, much of it sponsored by the US government, has shown CBD’s potential as a treatment for a wide range of conditions, including arthritis, diabetes, alcoholism, MS, chronic pain, schizophrenia, PTSD, depression, antibiotic-resistant infections, epilepsy, and other neurological disorders.

CBD has demonstrable neuroprotective and neurogenic effects, and its anti-cancer properties are currently being investigated at several academic research centers in the United States and elsewhere. Further evidence suggests that CBD is safe even at high doses.

​

BIOAVAILABILITY OF CBD -  bi·o·a·vail·a·bil·i·ty - noun: the proportion of a drug or other substance that enters the circulation when introduced into the body and so is able to have an active effect.

Bioavailability of CBD varies greatly depending on the method of administration. The averages for CBD bioavailability by method of administration are:

6% – 15% for oral CBD (swallowed and digested)

35% sublingual - absorbed directly through the mouth

40% for vaporized

up to - 62% for intranasal (applied through the nose)

​

​

CBD may help with

Acne
ADD and ADHD
Addiction
AIDS
ALS
Alzheimer's
Anorexia
Antibiotic Resistance
Anxiety
Atherosclerosis
Arthritis
Asthma
Autism
Bipolar
Cancer
Digestive Issues
Depression
Diabetes
Endocrine Disorders
Epilepsy and Seizures
Fibromyalgia
Glaucoma
Heart Disease
Huntington’s Disease
Inflammation
Irritable Bowel Syndrome
Kidney Disease
Liver Disease
Metabolic Syndrome
Migraine
Mood Disorders
Motion Sickness
Multiple Sclerosis (MS)
Nausea
Neurodegeneration
Chronic Pain
Obesity
OCD
Osteoporosis/Bone Health
Parkinson’s Disease
Prion/Mad Cow disease
PTSD
Rheumatism
Schizophrenia
Sickle Cell Anemia
Skin Conditions
Sleep Disorders
Spinal Cord Injury
Stress
Stroke and TBI

​

​

Potential Benefits Wheel